|
"Building a Pragmatic Road: An ISPOR Development Workshop on Moving the QALY Forward," held in early November, was an initial step in developing a thought-leader-driven research agenda concerning the quality-adjusted life-year (QALY). (Participation was via invitation only.)
Thought leaders have been debating the QALY’s methodology, assumptions, and ultimate user value over the past several years. At the ISPOR 10th Annual International Meeting Plenary Session held May 2005, Daniel Kahneman, PhD presented on the "Determinants of Health Economic Decisions in Actual Practice: The Role of Behavioral Economics". A summary of his presentation can be found at: Determinants of Health Economic Decision in Actual Practice: The Role of Behavioral Economics. An issues panel at ISPOR 11th Annual International Meeting held May 2006 (“Will the QALY Survive?”) sparked extensive interest, and participants called for the development of a research agenda.
This QALY Development Workshop was partly developed in response to this call for a research agenda. Participants in this consensus workshop include the three issue panelists (Daniel Kahneman, the Eugene Higgins Professor of Psychology and Professor of Public Affairs at Princeton University; Dennis G. Fryback, Professor of Population Health Sciences at the University of Wisconsin-Madison; and Alistair McGuire, Chair in Health Economics, London School of Economics) and the moderator (Michael Drummond, Professor of Health Economics at the University of York and Past President of ISPOR), as well as other key thought leaders on utility measurements and health care desicion-makers representatives.
At the workshop, participants debated 1) issues in valuing health outcomes; 2) interpretations of utility and valuing health; 3) retaining the QALY and maximizing additional methods; and 4) QALY’s user value for decision-makers.
A summary of the proceedings will be placed on the ISPOR Web site in early 2008.
QALY Workshop Participants- Norman Daniels, PhD, Harvard School of Public Health
- Paul Dolan, D.Phil, Imperial College, London
- Michael Drummond, D.Phil., University of York
- Dennis G. Fryback, PhD, University of Wisconsin-Madison
- Marthe Gold, MD, MPH, City University of New York Medical School
- Daniel Kahneman, PhD, Princeton University
- Mark Scott Kamlet, PhD, Heinz School of Public Policy and Management, Carnegie Mellon University
- Paul Kind, MSc, M.Phil., University of York
- Jennifer Elston Lafata, PhD, Center for Health Service Research, Henry Ford Health System, Detroit, Michigan
- Joseph Lipscomb, PhD, Emory University
- Alistair McGuire, PhD, London School of Economics
- Karl Matuszewski, MS, PharmD, University HealthSystem Consortium
- Erik Nord, PhD, Norwegian Institute of Public Health
- Steve E. Phurrough, MPA, MD, Office of Standards and Quality, Center for Medicare and Medicaid Services, U.S. Department of Health and Human Services
- Dennis Raisch, RPh, PhD, VA Cooperative Studies Program, Clinical Research Pharmacy, Albuquerque, NM
- Dennis Revicki, PhD, MEDTAP at United BioSource Corp.
- George Torrance, PhD, Professor Emeritus, McMaster University, Canada
- Milton C. Weinstein, PhD, Harvard School of Public Health
Observers
- Diana Brixner, RPh, PhD, University of Utah
- Martin L. Brown, PhD, National Cancer Institute
- Steven B. Clauser, PhD, National Cancer Institute
- William Lawrence, MD, MS, Agency for Healthcare Research and Quality
- Bryce Reeve, PhD, National Cancer Institute
- James A. Shuttinga, PhD, National Institutes of Health
- Andreas Maetzel, PhD, MD, MSc, Amgen (Europe) GmbH
Funding for this conference was made possible in part by grant 1R13 HS016841-01 from the Agency for Healthcare Research and Quality (AHRQ). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.
|